• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在人类肾移植中对尸体供体进行甲泼尼龙预处理。

Pretreatment of cadaver donors with methylprednisolone in human renal allografts.

作者信息

Chatterjee S N, Terasaki P I, Fine S, Schulman B, Smith R, Fine R N

出版信息

Surg Gynecol Obstet. 1977 Nov;145(5):729-32.

PMID:333644
Abstract

Fifty cadaveric kidney donors were randomly allocated to two groups. Group 1 received 5 grams of intravenously administered methylprednisolone two to four hours prior to organ harvesting after the pronouncement of brain death. Group 2, which served as the control group, received no pretreatment. Of 100 kidneys harvested, 16 were discarded for various reasons, and 84 were transplanted and were available for evaluation, 40 from the pretreatment group and 44 from the control group. The transplant centers using these kidneys were unaware of the status of the kidney they received, that is, whether it was from a pretreated or a control group. The two groups of kidneys, pretreated and control, did not differ according to the length of warm or cold ischemia time or presence of preformed cytotoxic antibodies. The difference in graft failure between the two groups at three months was insignificant, even when the two groups were compared according to the method of preservation used.

摘要

五十名尸体肾供体被随机分为两组。第一组在脑死亡宣告后、器官获取前两到四小时静脉注射5克甲基强的松龙。第二组作为对照组,未接受预处理。在获取的100个肾脏中,16个因各种原因被丢弃,84个被移植并可供评估,其中40个来自预处理组,44个来自对照组。使用这些肾脏的移植中心不知道他们所接收肾脏的状态,即它是来自预处理组还是对照组。预处理组和对照组的两组肾脏在热缺血或冷缺血时间长短或是否存在预先形成的细胞毒性抗体方面没有差异。即使根据所使用的保存方法对两组进行比较,两组在三个月时移植物失败的差异也不显著。

相似文献

1
Pretreatment of cadaver donors with methylprednisolone in human renal allografts.在人类肾移植中对尸体供体进行甲泼尼龙预处理。
Surg Gynecol Obstet. 1977 Nov;145(5):729-32.
2
Donor pretreatment in cadaver renal transplantation.尸体肾移植中的供体预处理
Surg Gynecol Obstet. 1977 Aug;145(2):183-8.
3
Donor pretreatment in an unselected series of cadaver renal allografts.在一系列未经选择的尸体肾移植中进行供体预处理。
Kidney Int Suppl. 1978 Jun(8):S99-102.
4
Role of donor age and acute rejection episodes on long-term graft survival in cadaveric kidney transplantations.供体年龄和急性排斥反应发作对尸体肾移植长期移植肾存活的作用。
Transplant Proc. 2005 Sep;37(7):2954-6. doi: 10.1016/j.transproceed.2005.08.038.
5
The LifeLink Foundation and cadaver kidney transplantation in Tampa.生命链接基金会与坦帕的尸体肾移植
Clin Transpl. 1999:149-58.
6
The UNOS scientific renal transplant registry. United Network for Organ Sharing.美国器官共享联合网络(UNOS)的科学肾脏移植登记处。
Clin Transpl. 1995:1-18.
7
The long-term outcome of tacrolimus in cadaveric kidney transplantation from non-heart beating donors.他克莫司在非心脏跳动供体尸体肾移植中的长期疗效。
Clin Transplant. 2005 Apr;19(2):153-7. doi: 10.1111/j.1399-0012.2005.00200.x.
8
Outcome of kidney transplantation from nonheart-beating versus heart-beating cadaveric donors.非心脏停搏与心脏停搏尸体供体肾移植的结果。
Transplantation. 2007 May 15;83(9):1193-9. doi: 10.1097/01.tp.0000261710.53848.51.
9
Renal donor pretreatment with cytotoxic agents: immunologically ineffective and damaging to the graft.肾供体使用细胞毒性药物预处理:免疫上无效且对移植物有损害。
Transplant Proc. 1977 Sep;9(3):1591-6.
10
The fate of glomerular mesangial IgA deposition in the donated kidney after allograft transplantation.同种异体肾移植后供肾肾小球系膜IgA沉积的命运。
Clin Transplant. 2004 Oct;18(5):536-40. doi: 10.1111/j.1399-0012.2004.00206.x.

引用本文的文献

1
Management of the Pediatric Organ Donor.小儿器官捐献者的管理
J Pediatr Pharmacol Ther. 2019 Jul-Aug;24(4):276-289. doi: 10.5863/1551-6776-24.4.276.
2
Effect of corticosteroid administration on neurologically deceased organ donors and transplant recipients: a systematic review and meta-analysis.皮质类固醇给药对脑死亡器官捐献者和移植受者的影响:一项系统评价和荟萃分析。
BMJ Open. 2017 Jun 30;7(6):e014436. doi: 10.1136/bmjopen-2016-014436.
3
Pharmacological immunosuppressive agents.药理免疫抑制剂。
Ulster Med J. 1981;50(Suppl 1):36-42.